Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice

Thromb Res. 1995 Jan 15;77(2):193-8. doi: 10.1016/0049-3848(95)91625-u.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Alprostadil / therapeutic use
  • Animals
  • Aspirin / therapeutic use
  • Bridged Bicyclo Compounds / therapeutic use
  • Collagen / toxicity
  • Diltiazem / therapeutic use
  • Drug Evaluation, Preclinical
  • Epinephrine / toxicity
  • Epoprostenol / administration & dosage
  • Epoprostenol / analogs & derivatives*
  • Epoprostenol / therapeutic use
  • Fatty Acids, Monounsaturated / therapeutic use
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / therapeutic use
  • Hydralazine / therapeutic use
  • Injections, Intravenous
  • Isosorbide Dinitrate / therapeutic use
  • Male
  • Mice
  • Nifedipine / therapeutic use
  • Nitroprusside / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Pulmonary Embolism / chemically induced
  • Pulmonary Embolism / prevention & control*
  • Superoxide Dismutase / therapeutic use
  • Vasodilator Agents / therapeutic use

Substances

  • Bridged Bicyclo Compounds
  • Fatty Acids, Monounsaturated
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Vasodilator Agents
  • S 145
  • Nitroprusside
  • Hydralazine
  • beraprost
  • Heparin
  • Collagen
  • Epoprostenol
  • Superoxide Dismutase
  • Diltiazem
  • Alprostadil
  • Nifedipine
  • Isosorbide Dinitrate
  • Aspirin
  • Epinephrine